Skip to Main Content

Author Details

Albert I Ko
Instituto Goncalo Moniz, Yale School of Public Health
1983
309
66
Richard Andrew Taylor (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38070701Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey.Int J Infect Dis2024
36222594MIF is a common genetic determinant of COVID-19 symptomatic infection and severity.QJM2023
37598213Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population.Nat Commun2023
37488607COVID-19 annual update: a narrative review.Hum Genomics2023
38076979Social determinants of adult COVID-19 vaccine acceptance and uptake in a Brazilian urban informal community: a longitudinal time-to-event study.medRxiv2023
37486929MPL36, a major plasminogen (PLG) receptor in pathogenic Leptospira, has an essential role during infection.PLoS Pathog2023
37493729Delay in the diagnosis and treatment of tuberculosis in prisons in Mato Grosso do Sul, Brazil.Rev Soc Bras Med Trop2023
35686341Testing Frequency Matters: An Evaluation of the Diagnostic Performance of a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Rapid Antigen Test in US Correctional Facilities.Clin Infect Dis2023
37090569Factors associated with differential seropositivity to <i>Leptospira interrogans</i> and <i>Leptospira kirschneri</i> in a high transmission urban setting for leptospirosis in Brazil.medRxiv2023
37242336Molecular Characterization of <i>Leptospira</i> Species Detected in the Kidneys of Slaughtered Livestock in Abattoirs in Gauteng Province, South Africa.Pathogens2023
36974986Nonsystematic Reporting Biases of the SARS-CoV-2 Variant Mu Could Impact Our Understanding of the Epidemiological Dynamics of Emerging Variants.Genome Biol Evol2023
37270953Zika virus RNA persistence and recovery in water and wastewater: An approach for Zika virus surveillance in resource-constrained settings.Water Res2023
37355266Simplified sewerage to prevent urban leptospirosis transmission: a cluster non-randomised controlled trial protocol in disadvantaged urban communities of Salvador, Brazil.BMJ Open2023
36408616Use of Whole-Genome Sequencing to Estimate the Contribution of Immune Evasion and Waning Immunity on Decreasing COVID-19 Vaccine Effectiveness.J Infect Dis2023
36817891Routine saliva testing for SARS-CoV-2 in children: Methods for partnering with community childcare centers.Front Public Health2023
36586415Nasal host response-based screening for undiagnosed respiratory viruses: a pathogen surveillance and detection study.Lancet Microbe2023
36913159Covid-19 vaccine acceptance among individuals incarcerated in Connecticut state jails.Health Justice2023
34139761Genetic Evidence for a Potential Environmental Pathway to Spillover Infection of Rat-Borne Leptospirosis.J Infect Dis2022
35710879Population dynamics of synanthropic rodents after a chemical and infrastructural intervention in an urban low-income community.Sci Rep2022
35384900Use of Recently Vaccinated Individuals to Detect Bias in Test-Negative Case-Control Studies of COVID-19 Vaccine Effectiveness.Epidemiology2022
35647574The role of prisons in disseminating tuberculosis in Brazil: A genomic epidemiology study.Lancet Reg Health Am2022
35378749Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu.medRxiv2022
35404948Rainfall and other meteorological factors as drivers of urban transmission of leptospirosis.PLoS Negl Trop Dis2022
35609110No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.PLoS Biol2022
35470025Unequal burden of Zika-associated microcephaly among populations with public and private healthcare in Salvador, Brazil.Int J Infect Dis2022
35668119Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2.Nat Commun2022
35605635Minimally-Invasive Resection of a Racemose Neurocysticercal Cyst.Am J Trop Med Hyg2022
35857771Evaluation of the impact of chemical control on the ecology of Rattus norvegicus of an urban community in Salvador, Brazil.PLoS One2022
35697361Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study.BMJ2022
35428672Closing the health inequity gap during the pandemic: COVID-19 mortality among racial and ethnic groups in Connecticut, March 2020 to December 2021.J Epidemiol Community Health2022
35366959Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.Lancet Infect Dis2022
35492362Biannual and Quarterly Comparison Analysis of Agglutinating Antibody Kinetics on a Subcohort of Individuals Exposed to <i>Leptospira interrogans</i> in Salvador, Brazil.Front Med (Lausanne)2022
36962720Why is leptospirosis hard to avoid for the impoverished? Deconstructing leptospirosis transmission risk and the drivers of knowledge, attitudes, and practices in a disadvantaged community in Salvador, Brazil.PLOS Glob Public Health2022
36550362Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein.Sci Rep2022
36439189Corrigendum: Escape of TLR5 recognition by <i>Leptospira</i> spp.: A rationale for atypical endoflagella.Front Immunol2022
36454733Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-control analysis.PLoS Med2022
36111781Linking rattiness, geography and environmental degradation to spillover <i>Leptospira</i> infections in marginalised urban settings: An eco-epidemiological community-based cohort study in Brazil.Elife2022
36074784Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey.PLoS Med2022
36148970Rickettsial Infections Causing Acute Febrile Illness in Urban Slums, Brazil.Emerg Infect Dis2022
36202800Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil.Nat Commun2022
35128418Predicting daily COVID-19 case rates from SARS-CoV-2 RNA concentrations across a diversity of wastewater catchments.FEMS Microbes2022
35217624Lack of association between pandemic chilblains and SARS-CoV-2 infection.Proc Natl Acad Sci U S A2022
35064122Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19.Nat Commun2022
35301314De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report.Nat Commun2022
35236394EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil.Trials2022
35051990Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination.Nat Med2022
35260762A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations.NPJ Digit Med2022
35194620Structural factors contributing to SARS-CoV-2 infection risk in the urban slum setting.medRxiv2022
35259186Association of renalase with clinical outcomes in hospitalized patients with COVID-19.PLoS One2022
35228707Multiscale PHATE identifies multimodal signatures of COVID-19.Nat Biotechnol2022
  • 1 - 50 of 309

Recommended Authors

University of California San Francisco School of Medicine
Career Start Year 2018
Number of shared co-authors 2
University College London Hospitals National Health Service Foundation Trust
Career Start Year 2010
Number of shared co-authors 0
Hinton State Laboratory Institute
Career Start Year 2009
Number of shared co-authors 7
Tulane University
Career Start Year 2007
Number of shared co-authors 3
Boston University
Career Start Year 2007
Number of shared co-authors 1
Stanford University
Career Start Year 2007
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2006
Number of shared co-authors 0
College of Public Health, University of Nebraska Medical Center
Career Start Year 2006
Number of shared co-authors 1
Clinical Center (CC)
Career Start Year 2006
Number of shared co-authors 0
University of North Carolina School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Geneva Center for Emerging Viral Diseases, Geneva University Hospitals
Career Start Year 2003
Number of shared co-authors 1
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 0
U.S. Centers for Disease Control and Prevention
Career Start Year 2002
Number of shared co-authors 5
Career Start Year 2001
Number of shared co-authors 0
University of Maryland
Career Start Year 2000
Number of shared co-authors 0
London School of Hygiene & Tropical Medicine
Career Start Year 1995
Number of shared co-authors 1
Marshfield Clinic Research Institute, Marshfield Clinic Health System
Career Start Year 1995
Number of shared co-authors 3
Geneva University Hospital
Career Start Year 1993
Number of shared co-authors 0
Oak Crest Institute of Science
Career Start Year 1992
Number of shared co-authors 2
University of California-San Francisco
Career Start Year 1991
Number of shared co-authors 14
University of California San Francisco School of Medicine
Career Start Year 1989
Number of shared co-authors 2
Mount Sinai Health System and University Health Network
Career Start Year 1989
Number of shared co-authors 1
Department of Geography & Emerging Pathogens Institute, University of Florida
Career Start Year 1987
Number of shared co-authors 2
University of Utah
Career Start Year 1987
Number of shared co-authors 0
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 4
University of Sao Paulo and LIM01-HCFMUSP
Career Start Year 1983
Number of shared co-authors 1
Italian Ministry of Health
Career Start Year 1977
Number of shared co-authors 0
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 2
NYU Grossman School of Medicine, NY Clinical Laboratories
Career Start Year 1975
Number of shared co-authors 2
University of California berkeley
Career Start Year 1971
Number of shared co-authors 4

Collaborators

Yale School of Public Health
Co-authored papers 60
School of Public Health, Yale University
Co-authored papers 39
Federal University of Mato Grosso do Sul
Co-authored papers 34
Yale School of Public Health
Co-authored papers 32
Yale University
Co-authored papers 31
Yale School of Medicine
Co-authored papers 27
Stanford University
Co-authored papers 24
Yale School of Public Health
Co-authored papers 24
Department of Microbial Pathogenesis Yale University New Haven
Co-authored papers 22
Yale School of Public Health
Co-authored papers 21
Yale University
Co-authored papers 20
University of Florida
Co-authored papers 18
Yale School of Public Health
Co-authored papers 15
Yale School of Public Health
Co-authored papers 14
Yale School of Medicine
Co-authored papers 13
Yale School of Public Health
Co-authored papers 12
Yale School of Medicine
Co-authored papers 11
Yale School of Public Health
Co-authored papers 11
Yale University School of Medicine
Co-authored papers 11
Yale University
Co-authored papers 11
Yale University School of Medicine
Co-authored papers 11
Yale University School of Medicine
Co-authored papers 10
Yale School of Medicine
Co-authored papers 10
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers 9
Yale University
Co-authored papers 9
State University of Mato Grosso do Sul
Co-authored papers 9
Yale University School of Medicine
Co-authored papers 9
Yale School of Public Health, Yale University
Co-authored papers 9
University of Nebraska Medical Center
Co-authored papers 9
Yale School of Public Health
Co-authored papers 8